Prognostic implications of CD44, NANOG, OCT4, and BMI1 expression in tongue squamous cell carcinoma.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29607565.
- Also identified by DOI 10.1002/hed.25158.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tongue squamous cell carcinoma (SCC) contains a cell subpopulation referred to as cancer stem cells (CSCs), which are responsible for tumor growth, metastasis, and resistance to chemotherapy and radiotherapy. The CSC markers have been used to isolate these cells and as biomarkers to predict overall survival. The CSC markers CD44, NANOG, OCT4, and BMI1 were investigated using reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) and immunohistochemistry and correlated with clinicopathological parameters. The CD44 overexpression was associated with disease-related death (P = 0.02) and worst prognosis. NANOG was upregulated in nontumoral margins and associated with T1/T2 classification, lymph node metastasis, and worst prognosis. OCT4 was associated with lymph node metastasis and worst overall survival. BMI1 and CD44v3 were overexpressed in tongue SCC. Coexpression of CD44<sup>++</sup> /NANOG<sup>++</sup> was associated with worst overall survival when compared with patients with CD44<sup>-/+</sup> /NANOG<sup>-/+</sup> . The CSC markers might play an important role not only in CSC trait acquisition but also in tongue SCC development and progression.
Medical subject headings
- Carcinoma, Squamous Cell
- Hyaluronan Receptors
- Nanog Homeobox Protein
- Octamer Transcription Factor-3
- Polycomb Repressive Complex 1
- Tongue Neoplasms